Compare PAYC & BIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | PAYC | BIO |
|---|---|---|
| Founded | 1998 | 1952 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Computer Software: Prepackaged Software | Biotechnology: Laboratory Analytical Instruments |
| Sector | Technology | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 8.9B | 8.7B |
| IPO Year | 2014 | N/A |
| Metric | PAYC | BIO |
|---|---|---|
| Price | $156.71 | $322.97 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 14 | 4 |
| Target Price | $220.31 | ★ $358.50 |
| AVG Volume (30 Days) | ★ 796.4K | 166.1K |
| Earning Date | 02-11-2026 | 02-12-2026 |
| Dividend Yield | ★ 0.96% | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 8.05 | N/A |
| Revenue | $2,001,300,000.00 | ★ $2,557,500,000.00 |
| Revenue This Year | $11.03 | $1.62 |
| Revenue Next Year | $8.80 | $2.26 |
| P/E Ratio | $19.45 | ★ N/A |
| Revenue Growth | ★ 9.72 | N/A |
| 52 Week Low | $151.75 | $211.43 |
| 52 Week High | $267.76 | $373.69 |
| Indicator | PAYC | BIO |
|---|---|---|
| Relative Strength Index (RSI) | 39.75 | 62.81 |
| Support Level | $151.75 | $300.26 |
| Resistance Level | $161.95 | $328.25 |
| Average True Range (ATR) | 3.77 | 7.10 |
| MACD | -0.18 | 2.67 |
| Stochastic Oscillator | 27.63 | 85.32 |
Founded in 1998, Paycom is a human capital management software-as-a-service provider addressing customer requirements surrounding payroll, talent acquisition, talent management, HR management, as well as time and labor. The company primarily services midsize businesses within the United States, targeting businesses with 50-10,000 employees. The company primarily generates revenue through the sale of subscriptions providing access to its HCM platform. To a lesser extent, the company also generates revenue from implementation services provided to customers as well as interest income generated from customer funds. As of fiscal 2024, the company serviced slightly over 37,500 customers and stored data on over 7 million employees.
Bio-Rad Laboratories, headquartered in Hercules, California, develops, manufactures, and sells products and solutions for the clinical diagnostics and life sciences markets. In clinical diagnostics (60% of sales), Bio-Rad sells test systems and specialized quality controls for clinical laboratories. In life sciences (40% of sales), it develops and manufactures instruments and reagents used in research, biopharmaceutical production, and food testing and has a leadership position in dPCR technology. The company is geographically diverse, with major markets in the Americas (about 40% of sales), Europe (about 30%), Asia (about 30%), and other. Bio-Rad owns approximately 33% of Sartorius, a lab and bioprocessing supplier that specializes in single-use technology used in biologics manufacturing.